(Q58481870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Christine J Harrison

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Gibson BE

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wheatley K

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hann IM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Stevens RF

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Webb D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

De Graaf SS

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2130-2138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403924

9 January 2020

exact match

0 references

cites work

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a statistician's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

New combination chemotherapy for relapsed acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Results of induction and consolidation treatment with intermediate and high-dose ara-C and m-AMSA containing regimens in patients with primarily failed or relapsed acute leukemia and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

High dose cytosine arabinoside in the management of refractory acute leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403924

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16304572%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference